Neurogene Inc (NGNE): יחס שווי שוק להכנסות

Neurogene Inc. utilizes certified international cold chains for the delivery of biocomponents. The scientific team's flexibility is ensured by outsourcing production and testing to external contractors. In-house facilities in Texas and New York guarantee the stability of development. The price-to-sales valuation reflects the price action, where 325.50 determines the current value of the metric.

To assess long-term overpayment risks for the investor, it is essential to analyze the P/S ratio, which compares the market capitalization of Neurogene Inc. (NGNE) to its annual revenue, identifying phases of market overheating through revenue multiple dynamics. This indicator allows for the correlation of business value with actual earnings, which is critical for a company whose stability is supported by independent research and production facilities in New York and Texas.